Mirati Therapeutics Inc (NASDAQ:MRTX)

Delayed Data
As of Aug 10
 +0.96 / +1.17%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Mirati Therapeutics Inc have a median target of 109.50, with a high estimate of 195.00 and a low estimate of 80.00. The median estimate represents a +31.96% increase from the last price of 82.98.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Buy stock in Mirati Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Nov 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.10%
Growthannually -23.75%


Growthquarterly -90.16%
Growthannually -87.16%
Key to the earnings and sales forecast charts.